Vimarsana
Biggest News Aggregation in the World

Shifeng Pan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shifeng Pan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shifeng Pan Today - Breaking & Trending Today

Odyssey recruits news investors to fund precision drug research - Vimarsana News

Odyssey recruits news investors to fund precision drug research

Published: October 13, 2022

BioPharma

Source: biopharmadive.com
Related Topics:
Ann ArborUnited StatesUnited KingdomGary GlickShifeng PanGenomics Institute Of The Novartis Research FoundationOdyssey TherapeuticsGeneral CatalystScorpion TherapeuticsGenomics InstituteNovartis Research Foundation
Odyssey Therapeutics Announces $218 Million Series A Financing to Advance Next Generation Inflammation and Oncology Medicines - Vimarsana News

Odyssey Therapeutics Announces $218 Million Series A Financing to Advance Next Generation Inflammation and Oncology Medicines

Published: December 10, 2021

Odyssey Therapeutics Announces $218 Million Series A Financing to Advance Next Generation Inflammation and Oncology Medicines - read this article along with other careers information, tips and advice on BioSpace

Source: biospace.com
Related Topics:
New YorkUnited StatesHong KongRockefeller UniversityHarvard UniversityNew York UniversityStanford UniversityColumbia UniversitySan FranciscoJoseph McdonaldCarll GordonCarl GordonCharles BaumJill CarrollStephen SoissonBristol Myers SquibbDavidl PomplianoNatalie DalesShifeng PanValerie OdegardRobert AbrahamGaryd GlickDamon Runyon Walter Winchell Cancer ResearchGenomics Institute Of The Novartis Research FoundationChemistry At Harvard University
Odyssey Therapeutics Announces $218 Million Series A Financing to Advance Next Generation Inflammation and Oncology Medicines - Vimarsana News

Odyssey Therapeutics Announces $218 Million Series A Financing to Advance Next Generation Inflammation and Oncology Medicines

Published: December 7, 2021

/PRNewswire/ -- Odyssey Therapeutics, a biotechnology company pioneering next generation precision immunomodulators and oncology medicines, today announced the...

Source: prnewswire.com
Related Topics:
United StatesHarvard UniversityJoseph McdonaldCarll GordonCarl GordonCharles BaumJill CarrollStephen SoissonBristol Myers SquibbDavidl PomplianoNatalie DalesShifeng PanValerie OdegardRobert AbrahamGaryd GlickDamon Runyon Walter Winchell Cancer ResearchGenomics Institute Of The Novartis Research FoundationChemistry At Harvard UniversityUniversity Of PittsburghRockefeller UniversityComputational Chemistry At Carnegie Mellon UniversityJohns Hopkins School Of MedicineYork UniversityStructural Protein Sciences At Merck Research LaboratoriesMolecular Biology At Harvard University
Odyssey Therapeutics Announces $218 Million Series A Financing to Advance Next Generation Inflammation and Oncology Medicines - Vimarsana News

Odyssey Therapeutics Announces $218 Million Series A Financing to Advance Next Generation Inflammation and Oncology Medicines

Published: December 7, 2021

/PRNewswire/ -- Odyssey Therapeutics, a biotechnology company pioneering next generation precision immunomodulators and oncology medicines, today announced the...

Source: prnewswire.com
Related Topics:
United StatesHarvard UniversityJoseph McdonaldCarll GordonCarl GordonCharles BaumJill CarrollStephen SoissonBristol Myers SquibbDavidl PomplianoNatalie DalesShifeng PanValerie OdegardRobert AbrahamGaryd GlickDamon Runyon Walter Winchell Cancer ResearchGenomics Institute Of The Novartis Research FoundationChemistry At Harvard UniversityUniversity Of PittsburghRockefeller UniversityComputational Chemistry At Carnegie Mellon UniversityJohns Hopkins School Of MedicineYork UniversityStructural Protein Sciences At Merck Research LaboratoriesMolecular Biology At Harvard University
A serial biotech entrepreneur launches his next startup with high-dollar backing - Vimarsana News

A serial biotech entrepreneur launches his next startup with high-dollar backing

Published: December 7, 2021

BioPharma

Source: biopharmadive.com
Related Topics:
Gary GlickJoseph McdonaldNatalie DalesShifeng PanRobert AbrahamAxel HoosBristol Myers SquibbGenomics Institute Of The Novartis Research FoundationOdyssey TherapeuticsOrbimed AdvisorsCapital ManagementGenomics InstituteNovartis Research FoundationVividion TherapeuticsScorpion Therapeutics